The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Cancer Immunology, Immunotherapy : Cii
Jenzer, Maximilian M; Keß, Peter P; Nientiedt, Cathleen C; Endris, Volker V; Kippenberger, Maximilian M; Leichsenring, Jonas J; Stögbauer, Fabian F; Haimes, Josh J; Mishkin, Skyler S; Kudlow, Brian B; Kaczorowski, Adam A; Zschäbitz, Stefanie S; Volckmar, Anna-Lena AL; Sültmann, Holger H; Jäger, Dirk D; Duensing, Anette A; Schirmacher, Peter P; Hohenfellner, Markus M; Grüllich, Carsten C; Stenzinger, Albrecht A; Duensing, Stefan S